chr16-2039928-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002528.7(NTHL1):c.911T>A(p.Leu304His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,449,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002528.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NTHL1 | NM_002528.7 | c.911T>A | p.Leu304His | missense_variant | 6/6 | ENST00000651570.2 | NP_002519.2 | |
NTHL1 | NM_001318193.2 | c.740T>A | p.Leu247His | missense_variant | 5/5 | NP_001305122.2 | ||
NTHL1 | NM_001318194.2 | c.581T>A | p.Leu194His | missense_variant | 6/6 | NP_001305123.1 | ||
NTHL1 | XM_047434171.1 | c.632T>A | p.Leu211His | missense_variant | 6/6 | XP_047290127.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NTHL1 | ENST00000651570.2 | c.911T>A | p.Leu304His | missense_variant | 6/6 | NM_002528.7 | ENSP00000498421.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000417 AC: 1AN: 239836Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 131070
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1449802Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 721570
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 27, 2023 | This sequence change replaces leucine, which is neutral and non-polar, with histidine, which is basic and polar, at codon 312 of the NTHL1 protein (p.Leu312His). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with NTHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 823190). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2024 | The p.L312H variant (also known as c.935T>A), located in coding exon 6 of the NTHL1 gene, results from a T to A substitution at nucleotide position 935. The leucine at codon 312 is replaced by histidine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at